sourcing the best research evidence in ophthalmology
Main finding: At 2 years, atropine 1% was effective in slowing the progression of low to moderate myopia
Study characteristics:
Participants: Age 6-12 years old -myopic refraction -1.0 to -6.0D -Astigmatism ≤ 1.5D
Intervention:
Group 1: Atropine 1% once at night Group 2: placebo once at night
No serious adverse events related to atropine were reported.
Share This Article :
Source Archive